Improved Reperfusion and Vasculoprotection by the Poly(ADP-Ribose)Polymerase Inhibitor PJ34 After Stroke and Thrombolysis in Mice
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Improved Reperfusion and Vasculoprotection by the Poly(ADP-Ribose)Polymerase Inhibitor PJ34 After Stroke and Thrombolysis in Mice
Authors
Keywords
Stroke, Recombinant tissue plasminogen activator, Reperfusion, Vasculoprotection
Journal
MOLECULAR NEUROBIOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-04-12
DOI
10.1007/s12035-018-1063-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early Treatment with Poly(ADP-Ribose) Polymerase-1 Inhibitor (JPI-289) Reduces Infarct Volume and Improves Long-Term Behavior in an Animal Model of Ischemic Stroke
- (2018) Youngchul Kim et al. MOLECULAR NEUROBIOLOGY
- Improving Cerebral Blood Flow after Arterial Recanalization: A Novel Therapeutic Strategy in Stroke
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
- (2017) Arnab Ray Chaudhuri et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Rucaparib: the past, present, and future of a newly approved PARP inhibitor for ovarian cancer
- (2017) LE Dockery et al. OncoTargets and Therapy
- PARP Inhibitors for Recurrent Ovarian Carcinoma: Current Treatment Options and Future Perspectives
- (2016) J. Sehouli et al. GEBURTSHILFE UND FRAUENHEILKUNDE
- Experimental design and analysis and their reporting: new guidance for publication in BJP
- (2015) Michael J Curtis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Poly(ADP-ribose) Polymerase-1 Inhibition in Brain Endothelium Protects the Blood—Brain Barrier under Physiologic and Neuroinflammatory Conditions
- (2014) Slava Rom et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Recombinant Tissue Plasminogen Activator Enhances Microglial Cell Recruitment after Stroke in Mice
- (2014) Sébastien Lenglet et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Another “String to the Bow” of PJ34, a Potent Poly(ADP-Ribose)Polymerase Inhibitor: An Antiplatelet Effect through P2Y12 Antagonism?
- (2014) Marie Lechaftois et al. PLoS One
- Molecular magnetic resonance imaging of brain–immune interactions
- (2014) Maxime Gauberti et al. Frontiers in Cellular Neuroscience
- To Look Beyond Vasospasm in Aneurysmal Subarachnoid Haemorrhage
- (2014) Giulia Cossu et al. Biomed Research International
- Enhanced NF- B Activity Impairs Vascular Function Through PARP-1-, SP-1-, and COX-2-Dependent Mechanisms in Type 2 Diabetes
- (2013) M. Kassan et al. DIABETES
- Prevention of rt-PA induced blood–brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice
- (2013) Fei Teng et al. EXPERIMENTAL NEUROLOGY
- Intravenous Thrombolysis for Acute Ischemic Stroke Occurring during Hospitalization for Transient Ischemic Attack
- (2013) Georgios Tsivgoulis et al. International Journal of Stroke
- Role of poly (ADP-ribose)-polymerase and its signaling pathway with renin-angiotensin aldosterone system in renal diseases
- (2013) Tian-Biao Zhou et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Reperfusion Therapy for Acute Ischemic Stroke: How Should We React to the Third Interventional Management of Stroke (IMS III) Trial?
- (2013) James F. Meschia et al. MAYO CLINIC PROCEEDINGS
- Poly(ADP-ribose): PARadigms and PARadoxes
- (2013) Alexander Bürkle et al. MOLECULAR ASPECTS OF MEDICINE
- AMPK 2 exerts its anti-inflammatory effects through PARP-1 and Bcl-6
- (2013) B. Gongol et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hemorrhagic Transformation: A Review of the Rate of Hemorrhage in the Major Clinical Trials of Acute Ischemic Stroke
- (2013) Eric S. Sussman et al. Frontiers in Neurology
- Experimental modeling of recombinant tissue plasminogen activator effects after ischemic stroke
- (2012) Mohamad El Amki et al. EXPERIMENTAL NEUROLOGY
- Combined therapy with PJ34, a poly(ADP-ribose)polymerase inhibitor, reduces tissue plasminogen activator-induced hemorrhagic transformations in cerebral ischemia in mice
- (2012) Marianne Haddad et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Poly(ADP-Ribose) Polymerase 1 Inhibition Improves Coronary Arteriole Function in Type 2 Diabetes Mellitus
- (2012) Soo-Kyoung Choi et al. HYPERTENSION
- A broad-spectrum matrix metalloproteinase inhibitor prevents hemorrhagic complications induced by tissue plasminogen activator in mice
- (2012) K. Mishiro et al. NEUROSCIENCE
- A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator
- (2012) M. Ishiguro et al. NEUROSCIENCE
- Administration of the PARP Inhibitor Pj34 Ameliorates the Impaired Vascular Function Associated With Enos−/− Mice
- (2012) Fred A. English et al. Reproductive Sciences
- Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke
- (2011) Arthur Liesz et al. BRAIN
- MP-124, a novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor, ameliorates ischemic brain damage in a non-human primate model
- (2011) Shigeru Matsuura et al. BRAIN RESEARCH
- Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase
- (2011) F Moroni et al. BRITISH JOURNAL OF PHARMACOLOGY
- Vascular plasticity in cerebrovascular disorders
- (2011) Lars IH Edvinsson et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Dissociation of Vasospasm and Secondary Effects of Experimental Subarachnoid Hemorrhage by Clazosentan
- (2011) Mohammed Sabri et al. STROKE
- PARP inhibitors: New tools to protect from inflammation
- (2010) Vincenzo Giansanti et al. BIOCHEMICAL PHARMACOLOGY
- Blockade of Acute Microglial Activation by Minocycline Promotes Neuroprotection and Reduces Locomotor Hyperactivity after Closed Head Injury in Mice: A Twelve-Week Follow-Up Study
- (2010) Shadi Homsi et al. JOURNAL OF NEUROTRAUMA
- Low Rates of Acute Recanalization With Intravenous Recombinant Tissue Plasminogen Activator in Ischemic Stroke
- (2010) Rohit Bhatia et al. STROKE
- Inhibition of Poly(ADP-Ribose) Polymerase Suppresses Inflammation and Promotes Recovery after Ischemic Injury
- (2009) Tiina M Kauppinen et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Intravenous Tissue Plasminogen Activator for Stroke: A Review of the ECASS III Results in Relation to Prior Clinical Trials
- (2009) Carolyn A. Cronin JOURNAL OF EMERGENCY MEDICINE
- Inflammation markers and prediction of post-stroke vascular disease recurrence: The MITICO study
- (2009) J. Castillo et al. JOURNAL OF NEUROLOGY
- Minocycline and Tissue-Type Plasminogen Activator for Stroke
- (2009) Livia S. Machado et al. STROKE
- Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice
- (2008) Marianne Haddad et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
- (2008) Werner Hacke et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now